SOURCE-LINKED INTELLIGENCE
KRAS Targeting in Oncogenic Systems: reconstructing the KRAS signalling network to identify optimal drug combinations
ded to establish an independent career that strengthens Europe’s capacity to tackle major challenges in oncology. KRAS-mutant cancer, therapeutic resistance, dynamic network modelling, interactomics, artificial intelligence, translational in vitro model, drug discovery
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 426533.76
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T05:31:32.981Z. This is not the publication date.